These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 9346327)
1. Contribution of endopeptidase 3.4.24.15 to central neurotensin inactivation. Vincent B; Jiracek J; Noble F; Loog M; Roques B; Dive V; Vincent JP; Checler F Eur J Pharmacol; 1997 Sep; 334(1):49-53. PubMed ID: 9346327 [TBL] [Abstract][Full Text] [Related]
2. Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin-induced analgesia and neuronal inactivation. Vincent B; Jiracek J; Noble F; Loog M; Roques B; Dive V; Vincent JP; Checler F Br J Pharmacol; 1997 Jun; 121(4):705-10. PubMed ID: 9208137 [TBL] [Abstract][Full Text] [Related]
3. Development of highly potent and selective phosphinic peptide inhibitors of zinc endopeptidase 24-15 using combinatorial chemistry. Jirácek J; Yiotakis A; Vincent B; Lecoq A; Nicolaou A; Checler F; Dive V J Biol Chem; 1995 Sep; 270(37):21701-6. PubMed ID: 7665587 [TBL] [Abstract][Full Text] [Related]
4. Potent inhibition of endopeptidase 24.16 and endopeptidase 24.15 by the phosphonamide peptide N-(phenylethylphosphonyl)-Gly-L-Pro-L-aminohexanoic acid. Barelli H; Dive V; Yiotakis A; Vincent JP; Checler F Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):621-5. PubMed ID: 1332678 [TBL] [Abstract][Full Text] [Related]
5. Phosphorus-containing peptides as mixed inhibitors of endopeptidase 3.4.24.15 and 3.4.24.16: effect on neurotensin degradation in vitro and in vivo. Vincent B; Dive V; Yiotakis A; Smadja C; Maldonado R; Vincent JP; Checler F Br J Pharmacol; 1995 Jul; 115(6):1053-63. PubMed ID: 7582503 [TBL] [Abstract][Full Text] [Related]
6. Role of endopeptidase 3.4.24.16 in the catabolism of neurotensin, in vivo, in the vascularly perfused dog ileum. Barelli H; Fox-Threlkeld JE; Dive V; Daniel EE; Vincent JP; Checler F Br J Pharmacol; 1994 May; 112(1):127-32. PubMed ID: 8032633 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and analgesic effects of N-[3-[(hydroxyamino) carbonyl]-1-oxo-2(R)-benzylpropyl]-L-isoleucyl-L-leucine, a new potent inhibitor of multiple neurotensin/neuromedin N degrading enzymes. Doulut S; Dubuc I; Rodriguez M; Vecchini F; Fulcrand H; Barelli H; Checler F; Bourdel E; Aumelas A; Lallement JC J Med Chem; 1993 May; 36(10):1369-79. PubMed ID: 8496905 [TBL] [Abstract][Full Text] [Related]
8. Fluorimetric assay of the neurotensin-degrading metalloendopeptidase, endopeptidase 24.16. Dauch P; Barelli H; Vincent JP; Checler F Biochem J; 1991 Dec; 280 ( Pt 2)(Pt 2):421-6. PubMed ID: 1747117 [TBL] [Abstract][Full Text] [Related]
9. Interactions between NTS2 neurotensin and opioid receptors on two nociceptive responses assessed on the hot plate test in mice. Bredeloux P; Costentin J; Dubuc I Behav Brain Res; 2006 Dec; 175(2):399-407. PubMed ID: 17074405 [TBL] [Abstract][Full Text] [Related]
10. Association of aminopeptidase N and endopeptidase 24.15 inhibitors potentiate behavioral effects mediated by nociceptin/orphanin FQ in mice. Noble F; Roques BP FEBS Lett; 1997 Jan; 401(2-3):227-9. PubMed ID: 9013892 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier. Bredeloux P; Cavelier F; Dubuc I; Vivet B; Costentin J; Martinez J J Med Chem; 2008 Mar; 51(6):1610-6. PubMed ID: 18321036 [TBL] [Abstract][Full Text] [Related]
12. Colocalization of neurotensin receptors and of the neurotensin-degrading enzyme endopeptidase 24-16 in primary cultures of neurons. Chabry J; Checler F; Vincent JP; Mazella J J Neurosci; 1990 Dec; 10(12):3916-21. PubMed ID: 2176676 [TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of endopeptidase 24.16 by dipeptides. Dauch P; Vincent JP; Checler F Eur J Biochem; 1991 Dec; 202(2):269-76. PubMed ID: 1761032 [TBL] [Abstract][Full Text] [Related]
14. Involvement of endopeptidase 24.15 in the inactivation of bradykinin by rat brain slices. McDermott JR; Gibson AM; Turner JD Biochem Biophys Res Commun; 1987 Jul; 146(1):154-8. PubMed ID: 2886123 [TBL] [Abstract][Full Text] [Related]
15. Rat kidney endopeptidase 24.16. Purification, physico-chemical characteristics and differential specificity towards opiates, tachykinins and neurotensin-related peptides. Barelli H; Vincent JP; Checler F Eur J Biochem; 1993 Jan; 211(1-2):79-90. PubMed ID: 8425555 [TBL] [Abstract][Full Text] [Related]
16. JMV 449: a pseudopeptide analogue of neurotensin-(8-13) with highly potent and long-lasting hypothermic and analgesic effects in the mouse. Dubuc I; Costentin J; Doulut S; Rodriguez M; Martinez J; Kitabgi P Eur J Pharmacol; 1992 Aug; 219(2):327-9. PubMed ID: 1425958 [TBL] [Abstract][Full Text] [Related]
17. Antinociceptive properties of inhibitors of endopeptidase 24.15. Kest B; Orlowski M; Molineaux CJ; Bodnar RJ Int J Neurosci; 1991; 56(1-4):141-9. PubMed ID: 1938129 [TBL] [Abstract][Full Text] [Related]
18. New hydroxamate inhibitors of neurotensin-degrading enzymes. Synthesis and enzyme active-site recognition. Bourdel E; Doulut S; Jarretou G; Labbe-Jullie C; Fehrentz JA; Doumbia O; Kitabgi P; Martinez J Int J Pept Protein Res; 1996 Aug; 48(2):148-55. PubMed ID: 8872532 [TBL] [Abstract][Full Text] [Related]
19. Purification and properties of a neurotensin-degrading endopeptidase from pig brain. Millican PE; Kenny AJ; Turner AJ Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):583-91. PubMed ID: 1905921 [TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of human endopeptidase 3.4.24.16. Comparison with the porcine counterpart indicates a unique cleavage site on neurotensin. Vincent B; Vincent JP; Checler F Brain Res; 1996 Feb; 709(1):51-8. PubMed ID: 8869556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]